SCHEMBL16124515

SCHEMBL16124515

COC(=O)[C@H](Cc1cc(I)c(Oc2ccc(OC)c(C)c2)c(I)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLK5 Q9Y337 1/20 0.43
▸ PCNA P12004 4/20 0.43
▸ TAS1R3 Q7RTX0 2/20 0.39
▸ TAS1R1 Q7RTX1 2/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ THRB P10828 4/20 0.39
▸ THRA P10827 3/20 0.39
▸ TACR1 P25103 2/20 0.38
▸ ITGB3 P05106 1/20 0.38
▸ ITGA2B P08514 1/20 0.38
▸ ITGA4 P13612 2/20 0.38
▸ ITGB7 P26010 2/20 0.38
▸ ACE P12821 1/20 0.38
▸ PPARG P37231 2/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ GABRP O00591 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14484751 0.93 ITGB3 (0.46) PCNASCN9ATHRBTHRAITGB3
SCHEMBL16124513 0.93 ITGB3 (0.46) PCNASCN9ATHRBTHRAITGB3
SCHEMBL23605443 0.83 KLK5 (0.47) KLK5TAS1R3TAS1R1TACR1ITGB3
SCHEMBL28956961 0.82 KLK5 (0.54) KLK5ITGB3ITGA2BITGA4ITGB7
SCHEMBL10431620 0.82 KLK5 (0.54) KLK5ITGB3ITGA2BITGA4ITGB7
SCHEMBL20556571 0.82 KLK5 (0.51) KLK5TACR1ITGB3ITGA2BITGA4
SCHEMBL12706536 0.82 KLK5 (0.51) KLK5TACR1ITGB3ITGA2BITGA4
SCHEMBL16124512 0.80 THRB (0.53) PCNATHRBTHRAPPARGLMNA
SCHEMBL28965033 0.79 KLK5 (0.47) KLK5PCNATACR1ACE
SCHEMBL23605588 0.79 KLK5 (0.47) KLK5PCNATACR1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF KLK5 3640/4885PCNA 2/4885TAS1R3 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback